<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font20 { font-size : 20; } .font22 { font-size : 22; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">MMB </span>
   <span class="font22">cells </span>
   <span class="font20">skin </span>
   <span class="font17">expression </span>
   <span class="font16">cell </span>
   <span class="font16">&amp;lt; </span>
   <span class="font16">STAT </span>
   <span class="font16">{border-style </span>
   <span class="font15">Figure </span>
   <span class="font15">JAK </span>
   <span class="font15">vehicle </span>
   <span class="font15">mice </span>
   <span class="font15">px;} </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">IgE </span>
   <span class="font15">topical </span>
   <span class="font14">DCs </span>
   <span class="font14">TSLP </span>
   <span class="font14">dendritic </span>
   <span class="font14">day </span>
   <span class="font14">dermatitis </span>
   <span class="font14">mast </span>
   <span class="font14">OXL </span>
   <span class="font14">group </span>
   <span class="font14">treatment </span>
   <span class="font13">Immunol. </span>
   <span class="font13">cytokines </span>
   <span class="font13">groups </span>
   <span class="font13">inflammatory </span>
   <span class="font13">mRNA </span>
   <span class="font13">tacrolimus </span>
   <span class="font13">JAK/JAK </span>
   <span class="font13">atopic </span>
   <span class="font13">group. </span>
   <span class="font13">immune </span>
   <span class="font13">lesion </span>
   <span class="font13">pathway </span>
   <span class="font13">group, </span>
   <span class="font13">inhibitor </span>
   <span class="font13">serum </span>
   <span class="font13">showed </span>
   <span class="font13">therapeutic </span>
   <span class="font12">CD, </span>
   <span class="font12">IL- </span>
   <span class="font12">JAK/STAT </span>
   <span class="font12">STAT, </span>
   <span class="font12">symptoms </span>
   <span class="font12">using </span>
   <span class="font12">.%, </span>
   <span class="font12">effect </span>
   <span class="font12">mean </span>
   <span class="font12">p-STAT, </span>
   <span class="font12">px; </span>
   <span class="font12">severity </span>
   <span class="font12">signaling </span>
   <span class="font12">significantly </span>
   <span class="font12">{font-family </span>
   <span class="font12">However, </span>
   <span class="font12">IL-, </span>
   <span class="font12">USA). </span>
   <span class="font12">Values </span>
   <span class="font12">allergic </span>
   <span class="font12">cells, </span>
   <span class="font12">clinical </span>
   <span class="font12">different </span>
   <span class="font12">differentiation </span>
   <span class="font12">efficacy </span>
   <span class="font12">font-size </span>
   <span class="font12">increased </span>
   <span class="font12">inhibitors </span>
   <span class="font12">level </span>
   <span class="font12">model </span>
   <span class="font12">ointment </span>
   <span class="font12">p-STAT </span>
   <span class="font11">(:), </span>
   <span class="font11">*** </span>
   <span class="font11">Analysis </span>
   <span class="font11">Atopic </span>
   <span class="font11">JAK, </span>
   <span class="font11">MMB; </span>
   <span class="font11">anti-mouse </span>
   <span class="font11">application </span>
   <span class="font11">demonstrated </span>
   <span class="font11">disease </span>
   <span class="font11">double; </span>
   <span class="font11">inhibiting </span>
   <span class="font11">mice. </span>
   <span class="font11">molecules </span>
   <span class="font11">pathways </span>
   <span class="font11">results </span>
   <span class="font11">role </span>
   <span class="font11">scores </span>
   <span class="font11">versus </span>
   <span class="font11">AD. </span>
   <span class="font11">Clin. </span>
   <span class="font11">DNCB </span>
   <span class="font11">IFN-Î³ </span>
   <span class="font11">Liu </span>
   <span class="font11">Med. </span>
   <span class="font11">Therefore, </span>
   <span class="font11">Y.J. </span>
   <span class="font11">added </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">cells. </span>
   <span class="font11">costimulatory </span>
   <span class="font11">data </span>
   <span class="font11">decreased </span>
   <span class="font11">diseases </span>
   <span class="font11">dose-dependent </span>
   <span class="font11">function </span>
   <span class="font11">group; </span>
   <span class="font11">human </span>
   <span class="font11">induce </span>
   <span class="font11">kinase </span>
   <span class="font11">lesions </span>
   <span class="font11">mouse </span>
   <span class="font11">new </span>
   <span class="font11">novel </span>
   <span class="font11">number </span>
   <span class="font11">observed </span>
   <span class="font11">phosphorylation </span>
   <span class="font11">reduced </span>
   <span class="font11">regulate </span>
   <span class="font11">response </span>
   <span class="font11">signal </span>
   <span class="font11">solid; </span>
   <span class="font11">thickness </span>
   <span class="font11">total </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">./j.jaci... </span>
   <span class="font11">Allergy </span>
   <span class="font11">DNCB-induced </span>
   <span class="font11">JAK-STAT </span>
   <span class="font11">MHCII </span>
   <span class="font11">MMB, </span>
   <span class="font11">Meanwhile, </span>
   <span class="font11">Momelotinib </span>
   <span class="font11">Moreover, </span>
   <span class="font11">Rev. </span>
   <span class="font11">TSLP-activated </span>
   <span class="font11">TSLP-induced </span>
   <span class="font11">Wang </span>
   <span class="font11">Watanabe </span>
   <span class="font11">according </span>
   <span class="font11">activated </span>
   <span class="font11">activates </span>
   <span class="font11">antibody </span>
   <span class="font11">barrier </span>
   <span class="font11">better </span>
   <span class="font11">bold </span>
   <span class="font11">bone </span>
   <span class="font11">chronic </span>
   <span class="font11">compared </span>
   <span class="font11">courier; </span>
   <span class="font11">effects </span>
   <span class="font11">em; </span>
   <span class="font11">epidermal </span>
   <span class="font11">expressed </span>
   <span class="font11">groups. </span>
   <span class="font11">highly </span>
   <span class="font11">inhibited </span>
   <span class="font11">levels </span>
   <span class="font11">manner. </span>
   <span class="font11">normal </span>
   <span class="font11">participate </span>
   <span class="font11">process </span>
   <span class="font11">proliferation </span>
   <span class="font11">promote </span>
   <span class="font11">provided </span>
   <span class="font11">pt;} </span>
   <span class="font11">reduction </span>
   <span class="font11">score </span>
   <span class="font11">statistical </span>
   <span class="font11">studies </span>
   <span class="font11">study, </span>
   <span class="font11">targeting </span>
   <span class="font11">transduction </span>
   <span class="font11">used </span>
  </p>
 </body>
</html>
